Susanna Cooper

Susanna Cooper is a Postdoctoral Research Scientist at the University of Oxford's Department of Physiology, Anatomy and Genetics, working in Professor Paul Riley's group under an MRC programme. Her research bridges cardiovascular science and cancer biology, focusing on immunomodulation post-cardiac injury and cardiac lymphangiogenesis.

• BSc in Biochemistry, Queen's University (Canada)
• MSc in Forensic Science, King's College London
• BHF-sponsored PhD in Cardiovascular Sciences, St. George's, University of London

Her work explores the cardiovascular side effects of cancer treatments, particularly kinase inhibitors like trametinib. Current studies investigate lymphatic system roles in heart attack recovery to optimize tissue repair environments.

Publications highlight her expertise in angiotensin II signaling, striatin protein functions, and cardiotoxicity of cancer drugs. She also contributed to defining commotio cordis, a traumatic heart injury mechanism.

• Scientific Award: British Heart Foundation (BHF)-sponsored PhD Studentship

Her affiliations include the Riley Group and collaborations in cardiovascular pathology and translational medicine.